Living with cancer involves more than just fighting the disease; it involves managing the intense side effects that come with modern treatments. For patients using targeted therapies like tyrosine kinase inhibitors or immune checkpoint inhibitors, these side effects can be overwhelming. New evidence suggests that nurse-led interventions can make a significant difference in how patients experience these treatments.
By focusing on education, self-management, and remote monitoring, these nursing programs help patients manage their symptoms more effectively. The data from 14 different studies showed that these interventions led to better medication adherence and a decrease in unplanned healthcare use. Patients also reported a better quality of life and improved psychosocial outcomes, meaning they felt better emotionally and mentally during their journey.
While these results are promising, the evidence is still growing. Some of the data came from guidelines or protocols that have not been fully tested in large trials yet. More research is still needed to specifically look at long-term outcomes and specific issues like nerve damage from certain drugs. For now, these programs show that having a nurse as a primary guide can help patients stay on track and feel better while receiving targeted cancer therapies.
